Analysis of neuropsychiatric diagnoses after montelukast initiation
<strong>Importance</strong> The evidence base for the association between montelukast and adverse neuropsychiatric outcomes is mixed and inconclusive. Several methodological limitations have been identified in the evidence base on the safety of montelukast in observational studies. <...
Main Authors: | Paljarvi, T, Forton, J, Luciano, S, Herttua, K, Fazel, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Medical Association
2022
|
Similar Items
-
Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data
by: Paljarvi, T, et al.
Published: (2022) -
Associations between antipsychotics and risk of violent crimes and suicidal behaviour in personality disorder
by: Herttua, K, et al.
Published: (2022) -
Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review
by: Chris Wai Hang Lo, et al.
Published: (2023-09-01) -
Cause-specific excess mortality after first diagnosis of bipolar disorder: population-based cohort study
by: Paljärvi, T, et al.
Published: (2023) -
Meta-analysis of the relationship between montelukast use and neuropsychiatric events in patients with allergic airway disease
by: Yakui Mou, et al.
Published: (2023-11-01)